BridgeMD
New treatment option for Spinal Cord Injuries
Official title Longitudinal Autonomic Characterization as a Predictor for Secondary Medical Complications Post-SCI
ClinicalTrials.gov ID: NCT07210437
What this study is testing
- What it's testing
- The purpose of this research is to learn about how the body is able to balance changes in blood pressure, how that changes over time, and how these changes impact a participant's risk of developing medical problems.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 75
You may be able to join if
- 18-75 years old
- Spinal cord injury with neurological level of injury from C6-T12
- ASIA Impairment Scale A-D.
- Either acute SCI \ 1 year since injury, n=8).
You likely can't join if
- Symptoms of cardiovascular (including, but not limited to: hypertension, stroke, chest pain, etc.), respiratory, peripheral neurological or autonomic...
- Women who are pregnant or lactating
- Taking or being administered a medication known to potentially have adverse interactions with phenylephrine
- In the judgement of the principal investigator, any illness or condition that will interfere with the patient's ability to comply with the protocol...
The study team makes the final eligibility decision.
Where it's taking place
- Rochester, Minnesota, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 75 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Rochester, Minnesota, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.